KMT2A and acute lymphoblastic leukemia: FLT3 overexpression, in addition to its activating mutations, has been documented in B-ALL, particularly in specific subtypes such as r-KMT2A, r-ZNF384, and high hyperdiploid ALL (20, 37–41).